The Inflammatory Bowel Disease Treatment market size is expected to reach $43.36 billion in 2030 at a CAGR of 9.8%, driven by IBD prevalence.
Read More
The Incretin-Based Drugs market size is expected to reach $39.25 billion in 2030 at a CAGR of 7.1%, driven by type 2 diabetes rise.
Read More
The Inactivated Vaccines market size is expected to reach $8.07 billion in 2030 at a CAGR of 5.1%, driven by infectious disease prevalence.
Read More
The Inactivated Polio And Rabies Vaccines market size is expected to reach $2.97 billion in 2030 at a CAGR of 5.5%, driven by vaccination demand.
Read More
The In Vivo Toxicology market size is expected to reach $7.79 billion in 2030 at a CAGR of 6.7%, driven by growing drug discovery activity.
Read More
The In Vitro Diagnostics Enzymes market size is expected to reach $3.25 billion in 2030 at a CAGR of 7.0%, driven by rising cancer prevalence.
Read More
The In Silico Protein Design market size is expected to reach $4.86 billion in 2030 at a CAGR of 20.9%, driven by personalized medicine demand.
Read More
The Immunotoxin market size is expected to reach $96.77 billion in 2030 at a CAGR of 7.8%, driven by breast cancer incidence.
Read More
Immunosuppressants Market Performance Outlook 2026–2030: Revenue to Hit $62.64 Billion at 13.1% CAGR
The Immunosuppressants market size is expected to reach $62.64 billion in 2030 at a CAGR of 13.1%, driven by autoimmune disease rise.
Read More
The Immuno-Oncology Drugs market size is expected to reach $226.31 billion in 2030 at a CAGR of 13.5%, driven by rising cancer incidence.
Read More